ACEOMEZ esomeprazole (as magnesium) 20 mg enteric coated tablet bottle pack

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

esomeprazole magnesium, Quantity: 22.264 mg

Available from:

Jubilant Pharma Australia Pty Ltd

Pharmaceutical form:

Tablet, enteric coated

Composition:

Excipient Ingredients: povidone; iron oxide red; crospovidone; hypromellose phthalate; hyprolose; lactose monohydrate; macrogol 400; methacrylic acid - ethyl acrylate copolymer (1:1); purified talc; microcrystalline cellulose; macrogol 6000; pregelatinised maize starch; glyceryl monostearate; polysorbate 80; light magnesium oxide; silicon dioxide; titanium dioxide; hypromellose; iron oxide yellow; maize starch; sucrose

Administration route:

Oral

Units in package:

56, 30

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

ACEOMEZ is indicated for: Gastro-Oesophageal Reflux Disease (GORD). ? treatment of erosive reflux oesophagitis ? long-term management of patients with healed oesophagitis to prevent relapse ? symptomatic treatment of gastro-oesophageal reflux disease (GORD),Patients requiring NSAID therapy. ? short-term treatment of upper gastrointestinal symptoms associated with non-steroidal anti- inflammatory drug NSAID (non-selective and COX-2 selective) therapy. ? healing of gastric ulcers associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy ? prevention of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drug NSAID (non-selective and COX-2 selective) therapy in patients at risk.,Prevention of rebleeding of gastric or duodenal ulcers following treatment with esomeprazole IV (available in other brands) solution by intravenous infusion. Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion.,In combination with appropriate antibiotics for: ? healing of duodenal ulcer associated with Helicobacter pylori ? eradication of Helicobacter pylori in patients with active or healed peptic ulcer

Product summary:

Visual Identification: Light pink coloured, oblong, biconvex, coated tablets debossed with 20 on one side and CE on the other.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Registered

Authorization date:

2020-05-04